Canada Biotechnology & Medical Research

Defence Therapeutics Inc (DTC)

Track

Track

Ticker: DTC Exchange: CNX
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Cesarone, Carrie Senior Officer of Issuer Officer
Transaction date
Sale
Price
87.35
Quantity 24,260 -15.1%
Value CA$3,823,844
Meterissian, Sarkis Director of Issuer Non-Executive Director
Transaction date
Sale
Price
182.96
Quantity 80,922 +12.6%
Value CA$4,317,004
Meterissian, Sarkis Director of Issuer Non-Executive Director
Transaction date
Sale
Price
173.80
Quantity 43,916 -4.1%
Value CA$1,687,980
2.9
Grauer, Daniel Kwin Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
2.80
Quantity 2,500 +33.3%
Value CA$7,000
2.9
Grauer, Daniel Kwin Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
2.90
Quantity 2,500 +50.0%
Value CA$7,250
2.9
Grauer, Daniel Kwin Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
3.50
Quantity 2,200
Value CA$7,700
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2024-11-15 2024-11-15 S Sale
Cesarone, Carrie

Senior Officer of Issuer

Officer
24,260 -15.1%
87.35
CA$3,823,844 		24,260 -15.1% 87.35 CA$3,823,844
2023-12-13 2023-12-08 S Sale
Meterissian, Sarkis

Director of Issuer

Non-Executive Director
80,922 +12.6%
182.96
CA$4,317,004 		80,922 +12.6% 182.96 CA$4,317,004
2023-11-24 2023-11-20 S Sale
Meterissian, Sarkis

Director of Issuer

Non-Executive Director
43,916 -4.1%
173.80
CA$1,687,980 		43,916 -4.1% 173.80 CA$1,687,980
2023-07-24 2023-07-24 B Purchase
2.9
Grauer, Daniel Kwin

Director of Issuer

Non-Executive Director
2,500 +33.3%
2.80
CA$7,000 		2,500 +33.3% 2.80 CA$7,000
2023-05-10 2023-05-08 B Purchase
2.9
Grauer, Daniel Kwin

Director of Issuer

Non-Executive Director
2,500 +50.0%
2.90
CA$7,250 		2,500 +50.0% 2.90 CA$7,250
2023-03-23 2023-03-20 B Purchase
2.9
Grauer, Daniel Kwin

Director of Issuer

Non-Executive Director
2,200
3.50
CA$7,700 		2,200 3.50 CA$7,700
Explore more

More insider trading research around Defence Therapeutics Inc

More insider trades in Canada
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America